Jordan Wiebe edited Coding_Coding_the_process_by__.html  about 8 years ago

Commit id: 32b24fe496b0eb3447eb52276d6713303011bb5d

deletions | additions      

       

genetic studies, and genome-wide association studies were excluded.  Meta-analyses were excluded to avoid redundancy, as we had already coded their  constituent studies individually. Studies combining original research with  meta-analysis were included so as to not exclude original research. (See Prisma Diagram).

An Diagram).

An  abstraction manual was formulated by D.H. to standardize the coding process. Each person was partnered with another so that all of the coding process was reviewed once over. The papers were analyzed for nine specific  pieces of information: outcome, measurement device,metric,  method of aggregation, primacy of outcome, whether the outcome was a harm or side effect  of an intervention, study design,sample size, &  study type. type, metric, & sample size. With regards to metric, when an outcome element was implicitly specified, we considered it specified. E.g., because quantifying survival is, by definition, measuring time to event, specific metric for survival analysis outcomes was coded as time to event. For survival, remission, and relapse, measurement device was coded as “N/A” because, besides a calendar, there is no measurement device. For outcomes reported using scales (e.g., NCI-CTC), metric was coded as "value at a time point" unless otherwise specified within the body of the article.  When coding sample size for studies including non-pediatric-ALL research, all study participants were counted, including adult patients and pediatric patients with a cancer other than ALL.

Analysis:


After 


Analysis:


After  coding, outcomes were grouped into eight domains for analysis: 1) Survival; 2) Mortality; 3) Remission; 4) Relapse; 5) Response to Treatment; 6) Adverse Event; 7) Cognitive  Event; 8) Other.